In summary, metabolic and transcriptional control through O-GlcNAcylation of key proteins of the JAK-STAT pathway has therapeutic targeting potential, but there is clearly still more to investigate in order to understand the full consequences of this modification in cancer. This evidence concerns the gene SOAT1 and cancer.